Prosecution Insights
Last updated: April 19, 2026
Application No. 18/435,409

CONFIGURATOR FOR REMOTE MANAGEMENT OF MEDICAL DEVICES

Non-Final OA §102§103§112
Filed
Feb 07, 2024
Examiner
ULRICH, NICHOLAS S
Art Unit
2179
Tech Center
2100 — Computer Architecture & Software
Assignee
Welch Allyn Inc.
OA Round
1 (Non-Final)
69%
Grant Probability
Favorable
1-2
OA Rounds
3y 4m
To Grant
77%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allow Rate
425 granted / 614 resolved
+14.2% vs TC avg
Moderate +8% lift
Without
With
+7.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
31 currently pending
Career history
645
Total Applications
across all art units

Statute-Specific Performance

§101
7.5%
-32.5% vs TC avg
§103
48.1%
+8.1% vs TC avg
§102
17.4%
-22.6% vs TC avg
§112
19.3%
-20.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 614 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION 1. Claims 1-20 are pending. Notice of Pre-AIA or AIA Status 2. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement 3. The IDS filed 2/07/2024 is considered. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. 4. Claims 3, 10, and 18 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 3, 10, and 18 recite the limitation "the one or more selections of the device component information and the functionalities". There is insufficient antecedent basis for this limitation in the claims. Claims 3, 10, and 18 depend from independent claims 1, 8, and 16, respectively. The independent claims recite “one or more selections of the first and second pluralities of selectors for a medical device asset”. While the independent claims further recite “a first plurality of selectors for enabling device component information in the remote management system; and a second plurality of selectors for enabling functionalities in the remote management system;” there is no limitations that requires selections of the device component information and the functionalities and therefore it is unclear whether the recited limitation in claims 3, 10, and 18 is referring back to the recited “one or more selections of the first and second pluralities of selectors for a medical device asset” or is referring to additional selections of device component information and functionalities. Accordingly, the claim is indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. If the limitation is meant to refer back to the previous limitation, the claims could recite “…the one or more selections of the first and second pluralities of selectors…” to overcome this rejection. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. 5. Claim(s) 1, 2, 4-9, 11-17, 19, and 20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Durrant et al. (US 2016/0294951 A1). In regard to claim 1, Durrant discloses an apparatus for configuring a remote management system that is used for remotely managing a plurality of medical device assets, the apparatus comprising: at least one processing device; and a memory device storing instructions which, when executed by the at least one processing device, cause the at least one processing device to (Fig. 2 and Paragraphs 0079-0087): display a user interface including: a first plurality of selectors for enabling device component information in the remote management system; and a second plurality of selectors for enabling functionalities in the remote management system (Paragraph 0070, Paragraph 0098, Paragraph 0099, Paragraph 0104, Paragraph 0105, TABLE 1, TABLE 2, Paragraph 0106, and Paragraph 0130: display of a GUI including a plurality of selectable options for configuring medical device options including information and functionalities); receive from the user interface one or more selections of the first and second pluralities of selectors for a medical device asset (Paragraph 0104: receive user input via the GUI to configure various configuration options of the medical device); and configure the remote management system to remotely manage the medical device asset based on the one or more selections of the first and second pluralities of selectors for the medical device asset (Paragraph 104: the configured options are provided to the medical device which causes the medical device to be configured according to the configured options). In regard to claim 2, Durrant discloses wherein the medical device asset is a patient support system, a vital signs monitoring device, or an eye imaging device (Paragraph 0072: medical devices including medical devices to monitor physiological parameters). In regard to claim 4, Durrant discloses wherein the instructions, when executed by the at least one processing device, further cause the at least one processing device to: configure the remote management system to enable a third-party user to interface with the medical device asset (Paragraph 0107: customer registration wizard providing creation of login credentials for a second service or entity). In regard to claim 5, Durrant discloses wherein the first plurality of selectors for the device component information enables configuration in the remote management system of the device component information for the medical device asset, the device component information including data relevant to one or more components of the medical device asset (Paragraph 0070, Paragraph 0105, TABLE 1, and TABLE 2). In regard to claim 6, Durrant discloses wherein the second plurality of selectors for the functionalities are selectable to enable in the remote management system functions including at least one of log file request and retrieval, preventative maintenance tracking, access point location tracking, firmware updates, and configuration updates for the medical device asset (Paragraph 0105, TABLE 1, TABLE 2, and Paragraph 0106). In regard to claim 7, Durrant discloses wherein the user interface further includes a third plurality of selectors for customizing reports in the remote management system for the medical device asset (Paragraph 0100 and TABLE 2). In regard to claims 8, 9, 11, and 12, method claims 8, 9, 11, and 12 correspond generally to apparatus claims 1, 2, 4, and 5, respectively, and recite similar features in method form, and therefore are rejected under the same rationale. In regard to claim 13, Durrant discloses further comprising: configuring preventative maintenance information for the medical device asset in the remote management system based on a selection of the first plurality of selectors (Paragraph 0100, TABLE 2, and Paragraph 0130). In regard to claims 14 and 15, method claims 14 and 15 correspond generally to apparatus claims 6 and 7, respectively, and recite similar features in method form, and therefore are rejected under the same rationale. In regard to claims 16, 17, and 19, medium claims 16, 17, and 19 correspond generally to apparatus claims 1, 2, and 4, respectively, and recite similar features in medium form, and therefore are rejected under the same rationale. In regard to claim 20, Durrant discloses wherein the instructions, when executed, further cause the at least one computing device to: configure the device component information relevant to at least one component of the medical device asset based on one or more selections of the first plurality of selectors (Paragraph 0070, Paragraph 0105, TABLE 1, and TABLE 2); configure preventative maintenance for the medical device asset in the remote management system based on one or more selections of the first plurality of selectors (Paragraph 0100, TABLE 2, and Paragraph 0130); and enable in the remote management system functionalities for the medical device asset based on one or more selections of the second plurality of selectors, the functionalities including one or more of log file request and retrieval, preventative maintenance tracking, access point location tracking, firmware updates, and configuration updates (Paragraph 0105, TABLE 1, TABLE 2, and Paragraph 0106). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. 6. Claim(s) 3, 10, and 18 is/are rejected under 35 U.S.C. 103 as being unpatentable over Durrant et al. (US 2016/0294951 A1) and further in view of Alvarez et al. (US 2022/0096852 A1). In regard to claim 3, while Durrant teaches the one or more selections, they fail to show the wherein the one or more selections of the device component information and the functionalities configure the remote management system to communicate with an internet of things network for remote management of the medical device asset, as recited in the claims. Alvarez teaches a remote monitoring of a medical device similar to that of Durrant. In addition, Alvarez further teaches one or more selections of the device component information and the functionalities to configure a remote management system to communicate with an internet of things network for remote management of a medical device asset (Paragraph 0095: selection to pair remote monitoring device that is connected to IOT network with medical device in order to remotely monitor the medical device over an IOT network). It would have been obvious to one of ordinary skill in the art, having the teachings of Durrant and Alvarez before him before the effective filing date of the claimed invention, to modify the one or more selections taught by Durrant to include the one or more selections of the device component information and the functionalities to configure a remote management system to communicate with an internet of things network for remote management of a medical device asset of Alvarez, in order to obtain wherein the one or more selections of the device component information and the functionalities configure the remote management system to communicate with an internet of things network for remote management of the medical device asset. It would have been advantageous for one to utilize such a combination as enabling enhanced remote monitoring and management of a medical device would have been obtained, as suggested by Alvarez (Paragraphs 0005-0006). In regard to claim 10, method claim 10 corresponds generally to apparatus claim 3 and recites similar features in method form and therefore is rejected under the same rationale. In regard to claim 18, medium claim 18 corresponds generally to apparatus claim 3 and recites similar features in medium form and therefore is rejected under the same rationale. Conclusion 7. The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Juergens et al. (US 2024/0203581 A1), see at least the abstract. Arrizza et al. (US 11996188 B2), see at least the abstract and Fig. 20. Davenport (US 2023/0238121 A1), see at least the abstract, Fig. 3, and Paragraph 0030. Ranjbar et al. (Design of an Iot-Based System for Smart Maintenance of Medical Equipment, IEEE, 2019). 8. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NICHOLAS S ULRICH whose telephone number is (571)270-1397. The examiner can normally be reached M-F 8-4. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Fred Ehichioya can be reached at (571)272-4034. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. 9. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Nicholas Ulrich/Primary Examiner, Art Unit 2179
Read full office action

Prosecution Timeline

Feb 07, 2024
Application Filed
Mar 13, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12602239
SYSTEMS AND METHODS FOR RESOLVING AN ERROR CONDITION OF A MEDICAL DEVICE
2y 5m to grant Granted Apr 14, 2026
Patent 12578844
DATA PROCESSING METHOD FOR INTERACTION MODE SWITCHING, ELECTRONIC DEVICE
2y 5m to grant Granted Mar 17, 2026
Patent 12572264
GRAPHICAL USER INTERFACE FOR ARTIFICIAL INTELLIGENCE/MACHINE LEARNING (AI/ML) COGNITIVE SIGNALS ANALYSIS
2y 5m to grant Granted Mar 10, 2026
Patent 12572255
NOTIFICATION MESSAGE DISPLAY METHOD AND APPARATUS, DEVICE, READABLE STORAGE MEDIUM, AND CHIP
2y 5m to grant Granted Mar 10, 2026
Patent 12561509
Page Layout Method and Apparatus
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
69%
Grant Probability
77%
With Interview (+7.6%)
3y 4m
Median Time to Grant
Low
PTA Risk
Based on 614 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month